Top Stories
First Report aims to reduce reporting and interpretation times amid growing imaging volumes and workforce shortages.
The partners will explore T-cell dysfunction in oncology and autoimmune diseases simultaneously.
The company said the findings add to a growing body of evidence that behaviour support may play a key role in modern weight management.
The companies have signed a licensing deal to develop an Alzheimer's blood test using ALZpath's pTau217 antibody.
The FDA-cleared platform pairs with Dexcom's Stelo biosensor to continuously track glucose levels.
Conference News
GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research ...
Insilico Medicine caps monumental week at BIO 2026: Secures landmark $2.5B partnership and dominates thought leadership | EurekAlert!CAMBRIDGE, MA — June 26, 2026 — Insilico Medicine (“Insilico”), a c...
Already adopted in more than 20 countries for fetal brain and heart examinations, Fetoly now introduces Full Fetus Anatomy, becoming the first Real-Time AI Ultrasound Assistant to provide comprehensiv...
At HLTH Europe, executives from Sanofi, Takeda, MSD and TransCelerate came together in a panel discussion to compare notes on where the European pharma sector is at in its digital journey and how it compares with other regions on the global stage.
Showcasing how advanced AI models are transforming clinical development and accelerating precision medicineWALTHAM, Mass.--(BUSINESS WIRE)-- BostonGene, leading developer of AI models for tumor and im...
